Reckitt Benckiser Group Receives Hold Rating from Commerzbank Corporates & Markets (RB)
Reckitt Benckiser Group (LON:RB)‘s stock had its “hold” rating reiterated by analysts at Commerzbank Corporates & Markets in a research report issued to clients and investors on Monday, ARN reports. They currently have a GBX 4,500 ($71.84) price target on the stock. Commerzbank Corporates & Markets’ price objective points to a potential upside of 3.47% from the company’s current price.
Shares of Reckitt Benckiser Group (LON:RB) opened at 4363.00 on Monday. Reckitt Benckiser Group has a 1-year low of GBX 3591.9998 and a 1-year high of GBX 4986.00. The stock’s 50-day moving average is GBX 4508.81 and its 200-day moving average is GBX 4644.. The company’s market cap is £31.873 billion.
Several other analysts have also recently commented on the stock. Analysts at Nomura reiterated a “buy” rating on shares of Reckitt Benckiser Group in a research note to investors on Friday. They now have a GBX 4,800 ($76.63) price target on the stock. Separately, analysts at Citigroup Inc. cut their price target on shares of Reckitt Benckiser Group from GBX 5,100 ($81.42) to GBX 5,000 ($79.82) in a research note to investors on Friday. They now have a “buy” rating on the stock. Finally, analysts at Barclays Capital reiterated an “equal weight” rating on shares of Reckitt Benckiser Group in a research note to investors on Friday. They now have a GBX 4,400 ($70.24) price target on the stock. Eight investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of GBX 4,620.51 ($73.76).
Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.